10-Q: Intel's Q3 Turnaround: Altera Divestiture & US Govt. Deals Boost Results

Intel reports a significant financial turnaround in Q3 2025, driven by strategic divestitures, US government funding, and private equity investments, despite ongoing legal challenges.

Summary

• Net income attributable to Intel surged to $4.06 billion in Q3 2025, a substantial improvement from a $16.64 billion loss in Q3 2024.
• Diluted EPS reached $0.90 in Q3 2025, up from $(3.88) in the prior year period.
• For the nine months ended September 27, 2025, net income attributable to Intel was $324 million, compared to a loss of $18.63 billion in the same period last year.
• Completed the divestiture of 51% of Altera on September 12, 2025, for $4.3 billion in net purchase consideration, resulting in a $5.5 billion pre-tax gain.
• Secured $5.7 billion in accelerated disbursements from the U.S. Department of Commerce under the CHIPs Act, alongside an agreement to issue equity and warrants to the U.S. government.
• Entered into agreements for private placement share sales totaling $7.0 billion: $2.0 billion to SoftBank Group (completed) and $5.0 billion to NVIDIA (pending closing).
• Initiated the 2025 Restructuring Plan in Q2 2025, aiming to reduce the core Intel workforce by approximately 15% by the end of fiscal 2025, incurring $2.2 billion in charges year-to-date.
• Recognized $1.0 billion in CHIPs Act grants and $5.1 billion in Advanced Manufacturing Investment Credit (AMIC) claims in the first nine months of 2025.

Sentiment

Score: 7

Explanation: The company demonstrated a strong financial turnaround in Q3, driven by strategic divestitures, government funding, and private investments. However, significant risks remain, including ongoing legal challenges, potential SEC accounting revisions, and the capital-intensive nature of its foundry strategy, which led to a credit rating downgrade.

Positives

• Net income attributable to Intel significantly improved to $4.06 billion in Q3 2025 from a $16.64 billion loss in Q3 2024.
• Diluted EPS rose to $0.90 in Q3 2025 from $(3.88) in Q3 2024.
• Nine-month net income attributable to Intel turned profitable at $324 million, compared to a $18.63 billion loss in the prior year.
• Gross profit increased by $3.2 billion (161%) in Q3 2025 compared to Q3 2024, largely due to the absence of significant asset impairment charges.
• Operating income improved to $683 million in Q3 2025 from a $9.06 billion loss in Q3 2024.
• The divestiture of 51% of Altera generated a $5.5 billion pre-tax gain and $4.3 billion in net cash proceeds.
• Received $5.7 billion in accelerated CHIPs Act disbursements from the U.S. government.
• Secured $7.0 billion in private placement share sales from SoftBank Group ($2.0 billion, closed) and NVIDIA ($5.0 billion, pending).
• Operating cash flows increased to $5.41 billion in the first nine months of 2025 from $5.12 billion in the prior year.
• Total cash and short-term investments increased to $30.94 billion as of September 27, 2025, from $22.06 billion at December 28, 2024.
• Total debt decreased to $46.55 billion as of September 27, 2025, from $50.01 billion at December 28, 2024.
• The "One Big Beautiful Bill Act" makes 100% bonus depreciation and domestic R&D cost expensing permanent and increases the AMIC credit rate to 35%.

Negatives

• Still reported a nine-month operating loss of $2.79 billion, despite significant improvement from the prior year.
• Credit rating downgraded from BBB+ to BBB in August 2025, citing execution risks, delayed deleveraging, and weaker demand.
• Ongoing legal proceedings, including VLSI patent litigation ($1.0 billion accrued charge) and an EC-imposed fine ($401 million accrued charge).
• SEC consultation pending regarding the accounting treatment of U.S. government transactions, which could lead to material revisions of Q3 financial results.
• Intel Foundry segment continues to report operating losses, though improved, with a $2.32 billion loss in Q3 2025 and a $7.81 billion loss year-to-date.
• CCG operating income decreased by $243 million in Q3 2025 due to higher client unit costs and inventory reserves.
• The U.S. government's significant equity interest (5.8%, potentially up to 13.8%) introduces risks related to voting influence, potential limitations on future strategic transactions, and adverse impacts on non-U.S. business.

Risks

• Uncertainty regarding the SEC's view on the accounting treatment for U.S. government transactions, which could lead to material revisions of Q3 2025 financial results and impact future periods.
• The U.S. government's significant equity ownership (5.8% as of September 27, 2025, potentially up to 13.8% with Escrowed Shares and Warrants) may subject the company to changes in laws/regulations, unilateral amendments by the DOC, legal challenges, and adverse reactions from various stakeholders.
• The U.S. government's equity position reduces the voting and governance rights of other stockholders and may limit future strategic transactions.
• Geopolitical tensions and conflicts, particularly in Israel, could disrupt wafer fabrication facilities and product development centers, with a significant portion of revenue generated from products manufactured in Israel.
• Ongoing IP litigation, including VLSI Technology LLC v. Intel (with a $1.0 billion accrued charge), could result in substantial fines, penalties, costly royalties, or injunctions.
• The European Commission imposed a $401 million fine for past anti-competitive practices, which is under appeal.
• Litigation related to security vulnerabilities (Spectre, Meltdown, Downfall) and segment reporting/foundry model are ongoing, with potential for unspecified damages.
• The design, development, and manufacturing of leading-edge semiconductor process technologies (nodes) are risky and capital-intensive, with potential for pausing or discontinuing Intel 14A and successor nodes if significant external customers are not secured.
• The company is not insured for business interruptions resulting from war or political violence in Israel, and property, plant, and equipment assets in Israel are self-insured for such losses.
• The elimination of future grant funding under the commercial CHIPs Act agreement and potential unwillingness of other government entities to provide future grants could limit access to capital or increase operating costs.
• The recent credit rating downgrade from BBB+ to BBB may affect future borrowing costs and access to capital markets.

Future Outlook

Intel expects to release the first SKU of products manufactured on its new leading-edge node, Intel 18A, by the end of 2025. The company continues to develop its derivative node, Intel 18A-P, and Intel 14A, with a focus on securing a significant external customer for Intel 14A. If a significant external customer is not secured for Intel 14A, the company may pause or discontinue its pursuit of Intel 14A and successor nodes. A majority of products are expected to be manufactured in Intel's own facilities utilizing nodes up to Intel 18A-P through at least 2030. Total R&D and MG&A expenses are expected to decrease in 2025 due to restructuring and cost-reduction measures, with the 2025 Restructuring Plan anticipated to be substantially complete by Q4 2025, reducing the core Intel workforce by approximately 15%. The company is also evaluating the future impact of the 'One Big Beautiful Bill Act' provisions.

Management Comments

• We would take a more disciplined approach to the deployment of capital.
• We intend to invest capital in future node development and additional or upgraded manufacturing facilities only where we have a clear line of sight to an acceptable return on that capital.
• By focusing on our customers and delivering the best semiconductor products to the market, manufactured on the most appropriate internal or external node from a performance and cost perspective, and only deploying capital on new nodes and manufacturing facilities where we believe they will yield an attractive return, we believe we can improve the competitiveness of our products business, and the overall financial results for the company.

Industry Context

Intel's strategic moves, including the Altera divestiture and significant investments in foundry capabilities (CHIPs Act funding, private placements), reflect a broader industry trend towards specialized manufacturing and increased focus on advanced process technologies and AI. The integration of NEX into CCG and DCAI aligns with the growing importance of AI and data center solutions in the semiconductor market. The emphasis on securing external foundry customers for future nodes like Intel 14A highlights the competitive landscape and the need for diversified revenue streams in the capital-intensive foundry business.

Management Changes

Corporate Governance

Legal Proceedings

• VLSI Technology LLC v. Intel: Accrued charge of $1.0 billion. Federal Circuit reversed a $675 million infringement finding, affirmed a $1.5 billion finding but vacated damages, and remanded for further damages proceedings. Intel can advance a license defense, with a jury verdict in Intel's favor on an underlying factual question related to this defense in May 2025.
• European Commission Competition Matter: Accrued charge of $401 million for a fine imposed in September 2023, based on a 2009 finding of payments to prevent rival product sales. Intel has appealed the EC's decision.
• Litigation Related to Security Vulnerabilities (Spectre, Meltdown, Downfall): U.S. consumer class action for Spectre/Meltdown was dismissed and affirmed on appeal. A new class action for the 'Downfall' vulnerability was dismissed with leave to amend, and the second amended complaint had nationwide class claims dismissed with prejudice, while subclass claims were denied dismissal. Plaintiffs have appealed.
• Litigation Related to Segment Reporting and Internal Foundry Model: A securities class action lawsuit and related stockholder derivative lawsuits are pending. The class action complaint was dismissed twice for failure to plead false or misleading statements, and plaintiffs have appealed. Derivative lawsuits are stayed.
• Eire Og Innovations v IBM et. al.: Multiple complaints filed since April 2024 alleging patent infringement by Intel and AMD CPUs. Intel is indemnifying several customers. Markman hearings and trials are scheduled for 2025-2026.
• Media Content Protection v Intel: Trial set for January 2026, with MCP seeking $66 million to $398 million in damages for royalties.

Related Party Transactions

• Altera Corporation: Following the divestiture, Intel retains a 49% minority investment accounted for under the equity method. Intel provides semiconductor wafer manufacturing services and corporate services under a transition services agreement to Altera.
• SLP VII Gryphon Aggregator, L.P. (SL Partners): Purchased 51% of Altera from Intel and Intel Americas, then contributed shares to Gryphon JV, L.P. with Intel. SL Partners have significant control over Gryphon JV's board and certain consent rights.
• U.S. Department of Commerce: Entered into a Warrant and Common Stock Agreement for accelerated CHIPs Act disbursements in exchange for equity and warrants.

Stakeholder Impact

• Shareholders: Experienced significant dilution from recent equity issuances (U.S. government, SoftBank, NVIDIA) but also benefited from a substantial pre-tax gain on the Altera divestiture and improved financial performance. The U.S. government's significant equity stake could impact future governance and strategic flexibility.
• Employees: Affected by the 2025 Restructuring Plan, which aims to reduce the core workforce by approximately 15%. The Intel 401(k) Savings Plan was amended to reflect SECURE 2.0 Act changes, impacting retirement benefits and procedures.
• Customers: Benefit from continued investment in advanced manufacturing and process technology roadmaps (Intel 18A, 18A-P, 14A), but may face supply chain risks from geopolitical tensions.
• Suppliers: May be impacted by Intel's disciplined approach to capital deployment and manufacturing capacity adjustments.
• U.S. Government: Became a significant equity holder (5.8%, potentially up to 13.8%) in Intel, providing substantial funding for semiconductor manufacturing expansion under the CHIPs Act, but also introducing potential regulatory and governance complexities.
• Creditors: The credit rating downgrade from BBB+ to BBB may affect future borrowing costs.

Next Steps

• Complete the 2025 Restructuring Plan by Q4 2025.
• Release the first SKU of products manufactured on the Intel 18A node by the end of 2025.
• Continue development of Intel 18A-P and Intel 14A, actively seeking a significant external customer for Intel 14A.
• Finalize working capital and other customary closing adjustments with SLP for the Altera divestiture.
• Conclude the accounting consultation with the SEC regarding U.S. government transactions.
• Close the private placement share sale agreement with NVIDIA.
• Monitor and manage potential construction delays for Fab 34 in Ireland and associated liquidated damages.
• Prepare for production commencement at Arizona SCIP chip factories in 2026.

Key Dates

Recommendation

While Intel has shown a strong financial turnaround in Q3 2025, driven by strategic divestitures and significant capital injections from the U.S. government and private placements, substantial uncertainties and risks persist. The pending SEC consultation on the accounting for U.S. government transactions could materially alter reported results. Ongoing, high-value legal disputes, the capital-intensive nature of its foundry strategy, and the recent credit rating downgrade present headwinds. The U.S. government's significant equity stake also introduces unique governance and strategic limitations. Given the mix of positive momentum and unresolved risks, a 'hold' recommendation is appropriate, advising investors to monitor the resolution of these uncertainties before making further investment decisions.

Keywords

Intel, Q3 2025, Earnings, Semiconductor, Altera Divestiture, US Government Funding, CHIPs Act, Foundry Business, Restructuring, Mobileye, NVIDIA, SoftBank, Financial Performance, Legal Proceedings, Intel 18A, Intel 14A, Corporate Governance, 401k Plan